Regeneron said on Monday its experimental drug helped patients preserve up to 51% of lean mass and lose more fat when used in ...

Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...

WASHINGTON, DC – Achyuta Rajaram, 17, of Exeter, NH, has been named the winner of won the top award in the Regeneron Science Talent Sea Achyuta Rajaram 2024, America’s oldest and most ...

Regeneron and Illumina have joined a major investment in health data specialist Truveta that will support the creation of a major new genome project. The two companies, along with 17 US health ...

Regeneron has moved closer to a regulatory filing for its BCMAxCD3 bispecific antibody linvoseltamab, the first of a series of bispecifics that is spearheading its oncology pipeline. New data from ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company’s products include EYLEA injection ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said that ...

While the RTX 5060 Ti, for instance, isn't exactly a 4K gaming card, it absolutely shines at 1080p (and even 1440p) games, and is probably the best graphics card for anyone still using the most ...

Regeneron Pharmaceuticals, Inc. (REGN) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings. Skip to content ...

Quad/Graphics $5.54 60.65% Rosenblatt Barton Crockett 72 %$8.9 → $8.9 Maintains Buy Get Alert 06/06/2025 TTD Buy Now Trade Desk $ ... Regeneron Pharmaceuticals $494.00 13.36% UBS Trung Huynh 71 ...